Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
about
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Molecular prediction of adjuva ...... on in two independent cohorts.
@en
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer
@nl
type
label
Molecular prediction of adjuva ...... on in two independent cohorts.
@en
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer
@nl
prefLabel
Molecular prediction of adjuva ...... on in two independent cohorts.
@en
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer
@nl
P2093
P2860
P1433
P1476
Molecular prediction of adjuva ...... on in two independent cohorts.
@en
P2093
Anker Hansen
Bruce Pratt
Ib Jarle Christensen
Jens Benn Sørensen
Jesper Ravn
Peter Buhl Jensen
Steen Knudsen
Thomas Jensen
P2860
P304
P356
10.1371/JOURNAL.PONE.0194609
P407
P577
2018-03-22T00:00:00Z